Smith & Nephew Earnings, Revenue beat In Q2

  • Investing.com
Smith & Nephew Earnings, Revenue beat In Q2

Investing.com - Smith & Nephew reported on Thursday second quarter earnings that beat analysts' forecasts and revenue that topped expectations.

Smith & Nephew announced earnings per share of $0.39 on revenue of $1.34B. Analysts polled by Investing.com anticipated EPS of $0.37 on revenue of $1.3B.

Smith & Nephew shares are down 3% from the beginning of the year and are trading at $1,464.50 , down-from-52-week-high.They are under-performing the FTSE 100 which is up 9.56% from the start of the year.

Smith & Nephew follows other major Healthcare sector earnings this month

Smith & Nephew's report follows an earnings missed by AstraZeneca on Thursday, who reported EPS of $0.9 on revenue of $8.22B, compared to forecasts EPS of $0.9029 on revenue of $7.4B.

GlaxoSmithKline had beat expectations on Wednesday with second quarter EPS of $0.281 on revenue of $8.09B, compared to forecast for EPS of $0.1982 on revenue of $7.6B.

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or

100